For the best experience on the Abcam website please upgrade to a modern browser such as
Rabbit polyclonal to TFAP4
ab28512 recognises Transcription factor AP-4 (TFAP4).
Predicted to work with:
A region within a synthetic peptide: EEEQRRAVIV KPVRSCPEAP TSDTASDSEA SDSDAMDQSR EEPSGDGELP, corresponding to C terminal amino acids 289-338 of Human TFAP4
Jurkat Cell Lysate. Human brain tissue
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
Preservative: 0.09% Sodium azide
Constituents: 2% Sucrose, PBS
Concentration information loading...
Protein A purified
Abpromise guarantee covers the use of
in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Use a concentration of 1.25 µg/ml. Predicted molecular weight: 39 kDa. Good results were obtained when blocked with 5% non-fat dry milk in 0.05% PBS-T.
Use at an assay dependent concentration.
Transcription factor that activates both viral and cellular genes by binding to the symmetrical DNA sequence 5'-CAGCTG-3'.
Contains 1 basic helix-loop-helix (bHLH) domain.
Information by UniProt
Activating enhancer binding protein 4 antibody
Activating enhancer-binding protein 4 antibody
AP 4 antibody
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TFAP4 antibody (ab28512)
ab28512 at 4.0-8.0 ug/ml, staining TFAP4 in human brain cells (neural cells) by immunohistochmistry, paraffin embedded tissue.
Cells with positive label indicated with arrows.
Western blot - Anti-TFAP4 antibody (ab28512)
Anti-TFAP4 antibody (ab28512) at 1.25 µg/ml + Jurkat Cell Lysate
Secondary Rabbit Anti-TFAP4 at 1/50000 dilution Predicted band size: 39 kDa
This product has been referenced in:
et al. AP4 positively regulates LAPTM4B to promote hepatocellular carcinoma growth and metastasis, while reducing chemotherapy sensitivity. Mol Oncol 12:373-390 (2018).
Read more (PubMed: 29337428) »
et al. Overexpression of transcription factor activating enhancer binding protein 4 (TFAP4) predicts poor prognosis for colorectal cancer patients. Exp Ther Med 14:3057-3061 (2017).
Read more (PubMed: 28912857) »
See all 4 Publications
for this product
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"